Your browser doesn't support javascript.
loading
Clinical and laboratory studies of the fate of intranasal allergen.
Rimmer, Janet; Santos, Conceição; Yli-Panula, Eija; Noronha, Virginia; Viander, Markku.
Affiliation
  • Rimmer J; Allergen Group, Woolcock Institute of Medical Research, Sydney, New South Wales, Australia; Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia.
  • Santos C; Allergen Group, Woolcock Institute of Medical Research, Sydney, New South Wales, Australia; Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia.
  • Yli-Panula E; Allergen Group, Woolcock Institute of Medical Research, Sydney, New South Wales, Australia; Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia; Department of Teacher Education, University of Turku, Turku, Finland.
  • Noronha V; Allergen Group, Woolcock Institute of Medical Research, Sydney, New South Wales, Australia; Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia.
  • Viander M; Allergen Group, Woolcock Institute of Medical Research, Sydney, New South Wales, Australia; Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia; Department of Medical Microbiology and Immunology, University of Turku, Turku, Finland.
PLoS One ; 10(5): e0127477, 2015.
Article in En | MEDLINE | ID: mdl-25969994
ABSTRACT

BACKGROUND:

The precise way in which allergen is handled by the nose is unknown. The objective of this study was to determine recovery of Der p 1 allergen following nasal administration and to determine whether Der p 1 can be detected in nasal biopsies after natural exposure and nasal challenge to allergen.

METHODS:

(1) 20 nonatopic non-rhinitics were challenged with Der p 1 and recovery was measured by ELISA in the nasal wash, nasal mucus and induced sputum up to 30 minutes. Particulate charcoal (<40 µm) served as control. (2) In 8 subjects (5 atopics), 30 to 60 minutes after challenge histological localisation of Der p 1 in the nasal mucosal epithelium, subepithelial mucous glands and lamina propria was performed. Co-localisation of Der p 1 with macrophages and IgE-positive cells was undertaken.

RESULTS:

(1) Less than 25% of total allergen was retrievable after aqueous or particulate challenge, most from the nasal mucus during 1-5 min after the challenge. The median of carbon particles recovered was 9%. (2) Prechallenge Der p 1 staining was associated with the epithelium and subepithelial mucous glands. After challenge there was a trend for greater Der p 1 deposition in atopics, but both atopics and nonatopics showed increases in the number of Der p 1 stained cells and stained tissue compartments. In atopics, increased eosinophils, macrophages and IgE positive cells co-localized with Der p 1 staining.

CONCLUSIONS:

Der p 1 allergen is detected in nasal tissue independent of atopic status after natural exposure. After challenge the nose effectively retains allergen, which remains mucosally associated; in atopics there is greater Der p 1 deposition and inflammatory response than in nonatopics. These results support the hypothesis that nasal mucus and tissue act as a reservoir for the inhaled Der p 1 allergen leading to a persistent allergic inflammatory response in susceptible individuals.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Allergens / Dermatophagoides pteronyssinus / Nasal Mucosa Limits: Adult / Animals / Female / Humans / Male / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2015 Document type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Allergens / Dermatophagoides pteronyssinus / Nasal Mucosa Limits: Adult / Animals / Female / Humans / Male / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2015 Document type: Article Affiliation country: Australia